Traders Buy Shares of Colgate-Palmolive (CL) on Weakness After Insider Selling

Investors bought shares of Colgate-Palmolive (NYSE:CL) on weakness during trading on Monday following insider selling activity. $78.06 million flowed into the stock on the tick-up and $48.19 million flowed out of the stock on the tick-down, for a money net flow of $29.87 million into the stock. Of all equities tracked, Colgate-Palmolive had the 22nd highest net in-flow for the day. Colgate-Palmolive traded down ($0.67) for the day and closed at $62.04Specifically, Director Helene D. Gayle sold 7,000 shares of the stock in a transaction that occurred on Thursday, May 10th. The shares were sold at an average price of $62.23, for a total transaction of $435,610.00. Following the completion of the sale, the director now directly owns 35,395 shares of the company’s stock, valued at approximately $2,202,630.85. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP John J. Huston sold 1,524 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $70.17, for a total transaction of $106,939.08. Following the sale, the senior vice president now directly owns 87,376 shares of the company’s stock, valued at $6,131,173.92. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 84,642 shares of company stock valued at $5,790,761. Insiders own 1.02% of the company’s stock.

A number of research firms have recently commented on CL. Citigroup increased their target price on Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Tuesday, January 30th. Barclays set a $75.00 target price on Colgate-Palmolive and gave the company a “hold” rating in a research report on Thursday, March 15th. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research report on Tuesday, January 30th. Jefferies Group reiterated a “hold” rating and set a $79.00 target price on shares of Colgate-Palmolive in a research report on Friday, January 26th. Finally, Stifel Nicolaus reiterated a “hold” rating and set a $75.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, April 18th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and three have assigned a buy rating to the company. Colgate-Palmolive currently has an average rating of “Hold” and an average price target of $76.74.

Get Colgate-Palmolive alerts:

The company has a quick ratio of 0.75, a current ratio of 1.08 and a debt-to-equity ratio of 64.85. The stock has a market cap of $54.70 billion, a P/E ratio of 21.48, a P/E/G ratio of 2.48 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 27th. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.73 by $0.01. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $4.01 billion. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. Colgate-Palmolive’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the company earned $0.67 earnings per share. equities analysts expect that Colgate-Palmolive will post 3.17 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 15th. Investors of record on Friday, April 20th were given a $0.42 dividend. The ex-dividend date was Thursday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.40. This represents a $1.68 dividend on an annualized basis and a yield of 2.73%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.54%.

Institutional investors and hedge funds have recently modified their holdings of the stock. Virtue Capital Management LLC bought a new stake in Colgate-Palmolive in the fourth quarter worth $104,000. Quadrant Capital Group LLC lifted its position in Colgate-Palmolive by 142.4% in the first quarter. Quadrant Capital Group LLC now owns 1,602 shares of the company’s stock worth $108,000 after buying an additional 941 shares during the last quarter. Centerpoint Advisors LLC bought a new stake in Colgate-Palmolive in the first quarter worth $112,000. Princeton Capital Management LLC bought a new stake in Colgate-Palmolive in the first quarter worth $117,000. Finally, Calton & Associates Inc. bought a new stake in Colgate-Palmolive in the fourth quarter worth $126,000. Institutional investors own 74.26% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.